NC-4016

· NanoCarrier Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NC-4016, covering 2018-02-23 to 2018-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]